Novel ultrasound-guided adrenal venous sampling in iodine contrast intolerant patients: two case reports.

IF 5.3 1区医学 Q1 ENDOCRINOLOGY & METABOLISM

European Journal of Endocrinology Pub Date : 2025-03-03 DOI:10.1093/ejendo/lvaf024

Yoshiaki Hishida, Kazuki Hashimoto, Ryota Mochizuki, Hiroki Yasuda, Tomoyuki Nagasaka, Yuki Deguchi, Yoshiya Sugiura, Kenichi Yokota, Nobuyuki Ohike, Masakatsu Sone

{"title":"Novel ultrasound-guided adrenal venous sampling in iodine contrast intolerant patients: two case reports.","authors":"Yoshiaki Hishida, Kazuki Hashimoto, Ryota Mochizuki, Hiroki Yasuda, Tomoyuki Nagasaka, Yuki Deguchi, Yoshiya Sugiura, Kenichi Yokota, Nobuyuki Ohike, Masakatsu Sone","doi":"10.1093/ejendo/lvaf024","DOIUrl":null,"url":null,"abstract":"<p><p>Adrenal venous sampling (AVS) is an important procedure for determining primary aldosteronism (PA) subtypes. To guide the catheter to the adrenal veins and confirm cannulation, an iodinated contrast medium (ICM) is typically used. As an ultrasound-based device, the AcuNav intracardiac echocardiography (ICE) catheter allows for real-time visualization of vessels, offering a safer and less invasive option for patients at risk of using ICM. This report introduces a novel AVS technique using the AcuNav ICE catheter in two patients with PA with contraindications to ICM. One patient had a documented ICM allergy, and the other had active bronchial asthma. The AcuNav ICE catheter successfully enabled cannulation of the adrenal veins in both cases without the need for ICM or alternative agents. This ultrasound-guided technique is novel for AVS and highlights the potential of this method for broader applications in the management of patients with PA with ICM intolerance.</p>","PeriodicalId":11884,"journal":{"name":"European Journal of Endocrinology","volume":" ","pages":"K21-K25"},"PeriodicalIF":5.3000,"publicationDate":"2025-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Endocrinology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ejendo/lvaf024","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

Abstract

Adrenal venous sampling (AVS) is an important procedure for determining primary aldosteronism (PA) subtypes. To guide the catheter to the adrenal veins and confirm cannulation, an iodinated contrast medium (ICM) is typically used. As an ultrasound-based device, the AcuNav intracardiac echocardiography (ICE) catheter allows for real-time visualization of vessels, offering a safer and less invasive option for patients at risk of using ICM. This report introduces a novel AVS technique using the AcuNav ICE catheter in two patients with PA with contraindications to ICM. One patient had a documented ICM allergy, and the other had active bronchial asthma. The AcuNav ICE catheter successfully enabled cannulation of the adrenal veins in both cases without the need for ICM or alternative agents. This ultrasound-guided technique is novel for AVS and highlights the potential of this method for broader applications in the management of patients with PA with ICM intolerance.

查看原文本刊更多论文

新型超声引导肾上腺静脉取样治疗碘造影剂不耐受患者：两例报告。

肾上腺静脉取样（AVS）是确定原发性醛固酮增多症（PA）亚型的重要程序。为了引导导管进入肾上腺静脉并确认插管，通常使用碘化造影剂（ICM）。作为一种基于超声的设备，AcuNav心内超声心动图（ICE）导管允许血管的实时可视化，为有使用ICM风险的患者提供更安全、侵入性更小的选择。本报告介绍了一种新的AVS技术，使用AcuNav ICE导管治疗两例有ICM禁忌症的PA患者。一名患者有记录的ICM过敏，另一名患者有活动性支气管哮喘。AcuNav ICE导管在不需要ICM或其他药物的情况下成功地实现了肾上腺静脉插管。这种超声引导技术对于AVS来说是新颖的，并且强调了这种方法在治疗伴有ICM不耐受的PA患者方面具有更广泛应用的潜力。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European Journal of Endocrinology 医学-内分泌学与代谢

CiteScore

9.80

自引率

3.40%

发文量

354

审稿时长

1 months

期刊介绍： European Journal of Endocrinology is the official journal of the European Society of Endocrinology. Its predecessor journal is Acta Endocrinologica. The journal publishes high-quality original clinical and translational research papers and reviews in paediatric and adult endocrinology, as well as clinical practice guidelines, position statements and debates. Case reports will only be considered if they represent exceptional insights or advances in clinical endocrinology. Topics covered include, but are not limited to, Adrenal and Steroid, Bone and Mineral Metabolism, Hormones and Cancer, Pituitary and Hypothalamus, Thyroid and Reproduction. In the field of Diabetes, Obesity and Metabolism we welcome manuscripts addressing endocrine mechanisms of disease and its complications, management of obesity/diabetes in the context of other endocrine conditions, or aspects of complex disease management. Reports may encompass natural history studies, mechanistic studies, or clinical trials. Equal consideration is given to all manuscripts in English from any country.